Immix Biopharma IMMX
NASDAQ IMMX
$8.30 -0.21 (-2.47%)
As of: Oct 22, 2026 · 12:16 PM EDT

Immix Biopharma (IMMX) Notes Payables (2020 - 2022)

Updated

Immix Biopharma (IMMX) posted Notes Payables of $50,000 for Q1 2022, unchanged from the prior quarter.

Analysis

Immix Biopharma (IMMX) Notes Payables (2020 - 2022) Analysis & Trends

  • In prior years, Immix Biopharma's Notes Payables was $50,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,171.71 Bn 1,140.30 Bn 19.71 Bn
2 Johnson & Johnson 642.13 Bn 560.65 Bn 17.26 Bn
3 AbbVie 501.64 Bn 474.75 Bn 12.70 Bn
4 Merck 375.66 Bn 330.04 Bn 12.21 Bn
5 Novartis Ag 302.79 Bn 266.78 Bn 11.24 Bn
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn
8 Gilead Sciences 193.69 Bn 167.89 Bn 6.22 Bn
9 Pfizer 172.47 Bn 119.12 Bn 10.94 Bn
10 Immix Biopharma 529.62 Mn 297.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 50,000.00
Dec 31, 2021 50,000.00
Dec 31, 2020 50,000.00
API Access

Immix Biopharma Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=IMMX&period=max&api_key=YOUR_API_KEY